trial

Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting

NCTId NCT00237289
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 287 (actual)
Sponsored by Ortho-McNeil Neurologics, Inc.
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
287 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2001-10
Primary completion
—
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
topiramate

Sponsors

Ortho-McNeil Neurologics, Inc.Lead Sponsor

Sites

0 total

Facts & assertions

3 sourced
Enrollment
287
Phase
PHASE3
Status
COMPLETED
relationships
The graph out of here
drug
topiramate
drug
lead_sponsor
Ortho-McNeil Neurologics, Inc.
company
indication
Mania
indication
Bipolar Disorder
indication
Psychotic Disorders
indication